ResMed (RMD) Appoints Desney Tan and John Hernandez to Its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
November 19, 2021 9:00 AM ESTTan is vice president and managing director of Microsofts Health and Life Science R&D Hernandez is Googles head of clinical research, health economics, and outcomes researchBoth leaders digital health experience at world-leading tech firms can help oversee ResMeds strategy to improve 250 million lives in 2025ResMeds board increases from eight to ten directors
SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX:... More
